NCT01845714

Brief Summary

Study Hypothesis: Former investigators indicated that keratoconus has a negative impact on vision-specific quality of life. This study attempts to confirm this statement and assess whether cross-linking and cross-linking combined with photorefractive keratectomy improve vision-specific quality of life, in a sample of keratoconus patients with 3-years follow-up.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2009

Longer than P75 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2009

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2011

Completed
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2012

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

April 30, 2013

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 3, 2013

Completed
Last Updated

January 18, 2017

Status Verified

January 1, 2017

Enrollment Period

2 years

First QC Date

April 30, 2013

Last Update Submit

January 14, 2017

Conditions

Keywords

KeratoconusCorneal cross LinkingTopo guided PRKQuality of Life

Outcome Measures

Primary Outcomes (1)

  • Vision Specific quality of Life (VS-QoL)

    3 years

Study Arms (2)

Cross Linking Group (CxL group)

ACTIVE COMPARATOR

Patients that received CXL

Procedure: Corneal Cross Linking

Cross Linking with topo-guided PRK (tCxL)

ACTIVE COMPARATOR

Patients that received tCxL

Procedure: Corneal Cross Linking combined with topoguided PRK

Interventions

Cross Linking Group (CxL group)
Cross Linking with topo-guided PRK (tCxL)

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • be diagnosed and classified as stage 1 keratoconus according to the Amsler-Krumeich classification system for keratoconus
  • present progressive keratoconus in consecutive corneal topographies, and/or changes in their refractive power.
  • Progressive keratoconus was defined when any of the following criteria was met for a period of 24 months:
  • an increase of 1.00 diopter (D) or more in the steepest keratometry measurement
  • an increase of 1.00 D or more in manifest cylinder
  • an increase of 0.50 D or more in manifest refraction spherical equivalent.

You may not qualify if:

  • glaucoma
  • suspicion for glaucoma
  • IOP-lowering medications
  • central corneal thickness (CCT) less than 400μm
  • K-readings more than 60D
  • history of herpetic keratitis
  • corneal scarring
  • severe eye dryness
  • pregnancy or nursing
  • current corneal infection
  • or underlying autoimmune disease KG members were further sub-divided into CxL and tCxL groups, according to their eligibility for treatment with CxL or CxL with tPRK. In order to be eligible for tCxL, group participants should, additionally, have CCT above 450μm.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Labiris G, Giarmoukakis A, Sideroudi H, Kozobolis V. Impact of keratoconus, cross-linking and cross-linking combined with topography-guided photorefractive keratectomy on self-reported quality of life: a 3-year update. Cornea. 2013 Sep;32(9):e186-8. doi: 10.1097/ICO.0b013e318296e13c. No abstract available.

MeSH Terms

Conditions

Keratoconus

Interventions

Corneal Cross-Linking

Condition Hierarchy (Ancestors)

Corneal DiseasesEye Diseases

Intervention Hierarchy (Ancestors)

PhotochemotherapyCombined Modality TherapyTherapeuticsDrug TherapyPhototherapy

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

April 30, 2013

First Posted

May 3, 2013

Study Start

April 1, 2009

Primary Completion

April 1, 2011

Study Completion

October 1, 2012

Last Updated

January 18, 2017

Record last verified: 2017-01